BioWorld Asia

May 5, 2004

Peptech, Agenix Merging In Effort To Create Australian Powerhouse

SYDNEY, Australia - Two biotech companies agreed to a share-swap merger in what they declare is the first move in building Australia's biggest pure biotech company, with more acquisitions to come. (BioWorld International) Read More

Serono Secures Rights To 4SC Program In Autoimmune Disease

Work On Telomere Mechanism Opens New Avenues Of Research

NicOx, Ferrer Enter Collaboration To Develop Dermatology Drugs

Genmab Moving HuMax-CD4 Into Pivotal Program In CTCL

Swedish Biotech Group Decries State Of The Industry In Country

Aptanomics, Nanosyn Enter Deal To Discover Drugs For Cancer

Pharming Moves rhC1INH Into Pivotal Study In Angioedema

Prana Draws $20M Investment Following Trial In Alzheimer's

Innogenetics, Third Wave Enter Distribution Pact For Europe

Scancell Gains Interim Funding For ImmunoBody Technology

Glycoform Secures Funding For Work In Carbohydrate Delivery

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 16, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 16, 2026.

SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

BioWorld Science

Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...